Insights On Trial Design

  1. Molasses in Study Startup Efficiencies

    Overview of a recent study conducted to try to determine why there is so much variation and why there are so many inefficiencies and delays in study startup.

  2. King Arthur’s Excalibur in ICH E6 (r2)

    What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.

  3. The Importance of Proactive Clinical Returns Planning

    Help sponsors design a more holistic strategy to their managing the clinical supply returns process.

  4. Strategies for Efficient Clinical Supply Management and Forecasting

    Engaging clinical supply management and forecasting adds value by evaluating different response strategies and contingency plans and can identify supply solutions that minimize or even potentially avoid supply chain disruptions.

  5. Avoiding Delays In Clinical Supply

    How sponsors can work effectively with clinical suppliers for accurate forecasting and comparator sourcing to avoid delays in clinical supply.

  6. Business and Cultural Considerations When Managing Clinical Supplies for Asia-Pacific Studies

    In addition to careful adherence with all applicable regulatory and Customs requirements, sponsors should understand and be sensitive to the cultural and business norms of each country included in their study.

  7. Addressing Placebo Response, Therapeutic Misconceptions And Expectations

    Improving outcomes in clinical trials and reducing the trend toward high placebo response across different therapeutic areas requires the involvement of multiple stakeholders.

  8. Removing Barriers To Specialty Therapies: Technology Brings Advantages, But Buyer Beware

    Learn about the latest healthcare technologies and standards, including what they can and cannot do, to streamline patient access to your specialty therapy. New technologies can significantly reduce the time to fill, and increase patient adherence with your specialty medication.

  9. Looking Ahead To 2018: Insights Into Clinical Research Trends From Industry Experts

    In this paper, some of our thought-leaders provide their insights on what they are watching for and what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.

  10. The Role Of Observational Research & Patient Registries In Evidence Generation

    Increasingly central in the course of drug development is the inclusion of observational studies, including registries, which provide insights missing from traditional interventional studies.